Villere St Denis J & CO LLC Bristol Myers Squibb CO Transaction History

Villere St Denis J & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $13,507 - $14,876	-186 Reduced 5.05%	3,500 $269,000
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $23,731 - $28,455	386 Added 11.7%	3,686 $269,000
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $176,979 - $206,316	3,300 New	3,300 $205,000
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $234,964 - $292,857	-4,650 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$59.92 - $68.98 $20,972 - $24,143	-350 Reduced 7.0%	4,650 $294,000
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $17,982 - $19,605	-300 Reduced 5.66%	5,000 $306,000
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $292,719 - $337,822	5,300	5,300 $337,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Villere St Denis J & CO LLC with notifications on news.